obovatol has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, IS; Han, SB; Hong, JT; Jeong, JH; Lee, YK; Moon, DC; Oh, KW; Song, JK; Yun, YP | 1 |
| Ock, J; Suk, K | 1 |
1 review(s) available for obovatol and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors.
Topics: Animals; Biphenyl Compounds; Chemistry, Pharmaceutical; Humans; Imidazoles; Inflammation; Microglia; Neurodegenerative Diseases; Neuroprotective Agents; Phenyl Ethers; Pyridines | 2012 |
1 other study(ies) available for obovatol and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Neurotrophic activity of obovatol on the cultured embryonic rat neuronal cells by increase of neurotrophin release through activation of ERK pathway.
Topics: Animals; Antigens, Differentiation; Biphenyl Compounds; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Drug Discovery; Embryo, Mammalian; MAP Kinase Signaling System; Nerve Growth Factor; Nerve Growth Factors; Neurites; Neurodegenerative Diseases; Neurogenesis; Neurons; Osmolar Concentration; Phenyl Ethers; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley | 2010 |